The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BeOne Medicines Ltd ADR shares valued at $1,222,380 were sold by Wang Lai on Jul 29 ’25. At $302.49 per share, Wang Lai sold 4,041 shares. The insider’s holdings dropped to 259 shares worth approximately $77992.67 following the completion of this transaction.
Also, Wang Lai sold 259 shares, netting a total of over 78,995 in proceeds. Following the sale of shares at $305.00 each, the insider now holds 0 shares.
Before that, Lee Chan Henry had sold 920 shares from its account. In a trade valued at $280,233, the SVP, General Counsel traded BeOne Medicines Ltd ADR shares for $304.60 each. Upon closing the transaction, the insider’s holdings decreased to 920 shares, worth approximately $0.0.
As published in their initiating research note from RBC Capital Mkts on April 07, 2025, BeOne Medicines Ltd ADR [ONC] has been an Outperform and the price target has been revised to $312. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early March. Earlier on September 18, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for ONC stock.
Analyzing ONC Stock Performance
On last trading session, BeOne Medicines Ltd ADR [NASDAQ: ONC] rose 0.40% to $301.13. The stock’s lowest price that day was $296.1801, but it reached a high of $303.6 in the same session. During the last five days, there has been a surge of approximately 1.58%. Over the course of the year, BeOne Medicines Ltd ADR shares have jumped approximately 87.11%. Shares of the company reached a 52-week high of $308.87 on 07/29/25 and a 52-week low of $172.67 on 01/08/25.
Support And Resistance Levels for BeOne Medicines Ltd ADR (ONC)
According to the 24-hour chart, there is a support level at 297.01, which, if violated, would cause prices to drop to 292.88. In the upper region, resistance lies at 304.43. The next price resistance is at 307.72. RSI (Relative Strength Index) is 67.40 on the 14-day chart, showing neutral technical sentiment.
Is BeOne Medicines Ltd ADR subject to short interest?
Stocks of BeOne Medicines Ltd ADR saw a sharp steep in short interest on 2025-07-15 dropping by -0.3 million shares to 1.62 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 1.92 million shares. A decline of -18.53% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.77 of the overall float, the days-to-cover ratio (short ratio) decline to 4.77.
Which companies own the most shares of BeOne Medicines Ltd ADR (ONC)?
In terms of BeOne Medicines Ltd ADR share price expectations, FactSet research, analysts set an average price target of 303.5 in the next 12 months, up nearly 1.19% from the previous closing price of $299.94. Analysts anticipate BeOne Medicines Ltd ADR stock to reach 348 by 2025, with the lowest price target being 259. On February 06, 2024, JP Morgan assigned a price target of “an Overweight” to the stock and resumed coverage with a $185.
